Navarra
At 3P Biopharmaceuticals there is a clear orientation towards achieving results, quality and continuous improvement. As a CMO, we offer specialized and highly customized s...
Madrid
Atrys is a biomedical company dedicated to provide diagnostic services and excelence medical treatments. It aims is to facilitate patients with individualized therapy, as well as to develop ...
La Coruña
CiQUS focuses its scientific objectives in the field of health, materials science and the development of new transformative and sustainable technologies. Its research groups add...
Asturias
The research at the CINN is devoted to the "Controlled Design of Multiscaled Multifunctional Materials" aiming at the development, characteri...
Madrid
Laboratorio especializado en genética molecular ...
Barcelona
The Institute for Bioengineering of Catalonia (IBEC) is an interdisciplinary research centre focused on bioengineering and nanomedicine, based in Barcelona. ...
Zaragoza
INYCOM Biotech S.A. is a new business project, supported by Inycom, focused on biotechnological services and products to laboratories. This biotechnological project was bor...
Madrid
Pall Biotech, a division of Pall Corporation (a Danaher company), delivers total product and service solutions to global researchers, developers and manufacturers of large and small molecule...
Madrid
With a portfolio of more than 3,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and gene...
Barcelona
Objectives * To become a reference centre in animal genomics. * To develop tools for molecular diagnosis based on the analysis of DNA of dif...
Barcelona
Transplant Biomedicals is a European company based in Barcelona aimed at developing novel medical strategies to improve organ, tissue and cellular preservation to overall enhan...
Barcelona
The Universitat Autònoma de Barcelona is known for excellence in research and quality in teaching, and is a prominent European university: on the Times Higher Education World Universi...
